Bank Julius Baer & Co
PACB icon

Bank Julius Baer & Co’s Pacific Biosciences PACB Stock Holding History

Bank Julius Baer & Co’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-80,583
Closed -$2.82M – 848
2021
Q2 		$2.82M Sell
80,583
-33,641
-29% -$978K 0.02% 246
2021
Q1 		$3.81M Sell
114,224
-100,348
-47% -$3.51M 0.03% 217
2020
Q4 		$5.57M Buy
+214,572
New +$3.65M 0.05% 179

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank Julius Baer & Co's PACB Position: Q3 2021 in Review

Bank Julius Baer & Co sold out of Pacific Biosciences (PACB) in Q3 2021, closing a stake of 80,583 shares — an estimated $2.82M sold.

Bank Julius Baer & Co first reported a position in PACB in Q4 2020 and held it in 3 quarters. The position peaked at $5.57M in Q4 2020. 246 funds tracked by Wall St. Rank hold PACB as of Q3 2021.

  • Bank Julius Baer & Co reported no remaining Pacific Biosciences position as of Q3 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 80,583 Pacific Biosciences shares in Q3 2021, an estimated $2.82M.
  • Bank Julius Baer & Co first reported a position in Pacific Biosciences in Q4 2020 and held it in 3 quarters.
  • Bank Julius Baer & Co's Pacific Biosciences position peaked at $5.57M in Q4 2020.
  • 246 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2021.

Based on Bank Julius Baer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.